1. Introduction {#sec1}
===============

Turner syndrome (TS) is a chromosome abnormality \[[@B1]\], occurring in 1 in 2500 to 1 in 3000 live-born girls \[[@B2]\]. Short stature is one of the most common physical features in girls with TS and growth hormone therapy is recommended for normalization of height \[[@B1]\]. According to Davenport \[[@B3]\], the mean final height in TS girls is 20 cm below the mean of the normal girls. The physiological variations during the growth makes difficult the construction of new height references for TS girls. The World Health Organization (WHO) \[[@B4]\] and the Centers for Disease Control and Prevention (CDC) \[[@B5]\] have constructed growth charts for children and adolescents in the general population, but the accuracy of these curves is questionable for monitoring the growth in TS girls. Saari et al. \[[@B6]\] tested the WHO curves \[[@B4]\] with longitudinal data of TS girls and demonstrated that the growth references of the WHO \[[@B4]\] may have important limitations for monitoring the growth of the children with potential morbidity. Thereby, growth curves for TS girls have been constructed in several countries. However, it is necessary to analyze the methodological and statistical aspects in order to provide accurate information for monitoring of growth in TS girls. Thus, the objectives of this study were to systematically (1) identify existing growth curves for TS girls (2) to evaluate the methodological and statistical quality (3) and to suggest potential growth curves for clinical practice guidelines.

2. Methods {#sec2}
==========

2.1. Search Strategy {#sec2.1}
--------------------

Search strategies were developed together with an expert librarian of the health field. The search was carried out from September to October 2013 in databases: Medline (1950--2013) and Embase (1988--2013). The terms were restricted in English and consulted according to the Medical Subject Headings (MeSH): Turner syndrome, growth chart, growth curve, growth, pattern, standard, reference, value, weight, length, height, velocity, head circumference, body mass index, and BMI, with the possible suffixes. The references of the selected papers were also reviewed. The studies were identified by the electronic search by two independent reviewers. The date of the last search was October 15, 2013.

2.2. Study Selection {#sec2.2}
--------------------

The search process was developed according to the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) method \[[@B7]\]. Two independent reviewers evaluated the potentially relevant studies. Inclusion criteria were (1) original papers, and (2) construction of curves for weight, length/height, growth velocity, head circumference, and BMI. Papers were not excluded by the use of hormonal therapy, sample size, other methodological limitations, and inappropriate statistical analysis.

2.3. Data Extraction {#sec2.3}
--------------------

The data were extracted according to the international guidelines for the development of growth curves \[[@B4]\]. Discrepancies between reviewers were discussed and resolved by consensus meeting. Data extracted: size sample; number of observations; size sample by karyotype (%); age; type of study; hormone therapy (type, occurrence, and age); spontaneous puberty (percentage, frequency, and age); occurrence of menarche (percentage, frequency, and age); birth year period; growth variable; country; statistical method (mean, standard deviation, percentiles,*z*-scores, smoothing aspects); exclusion criteria; and outcomes.

2.4. Data Analysis {#sec2.4}
------------------

Papers that did not provided the total number of observations (*n* ^2^) were subjected to mathematical calculations. Thus, the tables were consulted and *n* ^2^ was calculated (sum of number of observations by age). Furthermore, percentage frequency (%) was calculated to provide the occurrence of puberty, menarche, and karyotypes.

3. Results {#sec3}
==========

3.1. Study Selection {#sec3.1}
--------------------

The search in the electronic databases identified 1,006 studies. The exclusion of papers occurred in three phases: (a) duplicates (*n* = 141); (b) papers that did not evaluate growth charts (*n* = 777); (c) papers on growth pattern, body proportion, and bone development (*n* = 73). The references of the selected papers were not used (*n* = 0). After the eligibility, 15 papers were included in this review \[[@B8]--[@B22]\]. The search results are presented in [Figure 1](#fig1){ref-type="fig"}.

3.2. Characteristics of Studies {#sec3.2}
-------------------------------

### 3.2.1. Participants {#sec3.2.1}

The sample size ranged between 47 and 1,565 TS girls (total = 6,273) aged 0 to 24 y, born between 1950 and 2006. Hormone therapy treatment (estrogen and growth hormone) was observed in girls aged 11.3 to 24.6 y, spontaneous menarche occurrence (aged 11 to 22 y), and spontaneous puberty occurrence (variation: 1.4 to 18.4% of sample)---[Table 1](#tab1){ref-type="table"}. The karyotype 45,X was reported in most studies ([Table 2](#tab2){ref-type="table"}).

### 3.2.2. Growth Curves {#sec3.2.2}

The curves were generated for: weight-for-age; height-for-age; weight-for-height; BMI-for-age; head circumference-for-age; height velocity (cm/year/age) ([Table 1](#tab1){ref-type="table"}). In addition, leg length-for-age and sitting height-for-age \[[@B15]\] also were constructed, but not analyzed in this study. The studies used longitudinal and cross-sectional samples analyzing data collected from 1960 to 2008 ([Table 1](#tab1){ref-type="table"}). The number of anthropometric measurements ranged between 580 and 9,011 (total = 28,915).

### 3.2.3. Exclusion Criteria {#sec3.2.3}

The exclusion criteria applied by the studies were hormone therapy (growth hormone and/or androgen \[[@B8], [@B11], [@B12], [@B14], [@B16], [@B18]--[@B22]\]; estrogen \[[@B12], [@B18], [@B19]\]); diseases (diabetes \[[@B10], [@B11]\], hypothyroidism \[[@B10], [@B11]\], hyperthyroidism \[[@B11]\], polyarthritis \[[@B10]\], heart problems \[[@B11], [@B14], [@B18]\], and kidney problems \[[@B11], [@B14]\]); specific karyotypes including the Y chromosome \[[@B11], [@B19]\]; concomitant autosomal chromosome abnormalities \[[@B18]\]; records that did not include at least two successive annual measurements \[[@B15]\]; spontaneous puberty \[[@B16], [@B18], [@B20], [@B21]\]; gestational age (\<37 weeks) \[[@B18]\]; age over 20 years \[[@B20]\]; lack of records about puberty \[[@B20]\]; highly unlikely measurements \[[@B20]\]; and outliers \[[@B21]\].

### 3.2.4. Types of Curves Generated {#sec3.2.4}

The growth curves were constructed using the mean, standard deviation, percentiles,*z*-scores, and smoothing techniques. Seven studies \[[@B8]--[@B10], [@B14], [@B16], [@B19], [@B20]\] provided the number of observations with the respective means and standard deviations by age ([Table 3](#tab3){ref-type="table"}). Suwa \[[@B11]\] showed the means and standard deviations of height at each month in girls aged 0 to 20 y without and with genital bleeding. The age intervals up to the two years were as follows: (a) every one year \[[@B8], [@B9], [@B11]--[@B15], [@B19], [@B21], [@B22]\]; (b) every 6 months \[[@B20]\]; (c) every 3 months \[[@B16]--[@B18]\]. The growth was analyzed according to karyotypes \[[@B9]--[@B13], [@B15], [@B17]--[@B21]\], parents\' height \[[@B9], [@B10], [@B13]\], hormone therapy \[[@B8], [@B10], [@B14], [@B15]\], spontaneous puberty \[[@B9], [@B12]--[@B14], [@B19]\], and spontaneous menarche \[[@B8], [@B10], [@B11], [@B13], [@B14]\]. Percentiles curves were generated for weight-for-age, height-for-age, leg length-for-age, sitting height-for-age, and height velocity \[[@B8], [@B12]--[@B15], [@B18], [@B20]\]. The percentiles were generated for the following lines: 3rd, 10th, 25th, 50th, 75th, 90th, and 97th \[[@B14], [@B15], [@B20]\]. Other studies (*n* = 7) \[[@B9]--[@B11], [@B16], [@B17], [@B21], [@B22]\] derived the percentiles within the values corresponding to the*z*-score −2 and +2. Román et al. \[[@B19]\] presented only the values of mean and standard deviation by age.

### 3.2.5. Smoothing Aspects {#sec3.2.5}

The smoothing techniques for construction of growth curves were performed in 80% of the studies \[[@B8], [@B11]--[@B18], [@B20]--[@B22]\]. Examples of these methods included (1) 4253H-twice for smoothing the data but without giving specific detail \[[@B13]\], (2) "moving mean" technique to correct the height at each month of age \[[@B11]\], (3) fifth-degree polynomial applied to smooth the mean and standard deviation of height, in order to calculate and select the centile \[[@B14]\], (4) degree polynomial to mean and standard deviation of height, weight-for-age separately for age 0--2 years and for 2--17 years, and weight-for-height \[[@B16]\], (5) splines for each individual height curve to give the individual velocity height \[[@B17]\], (6) LMS methods for BMI curves \[[@B16]\], weight and height curves \[[@B20]\], weight, weight-for-height, and BMI curves \[[@B21]\]. Others studies \[[@B8], [@B12], [@B15], [@B18]\] used smoothing techniques but did not described the exact techniques for constructing the growth curves.

3.3. Outcomes {#sec3.3}
-------------

### 3.3.1. TS Girls versus Normal Girls {#sec3.3.1}

The growth references were compared using standard deviation score (SDS) for girls with TS and normal girls, \[[@B8], [@B14], [@B16]--[@B18], [@B22]\]. The growth in TS girls was significantly lower in comparison to normal girls (SDS: −0.15 to −2.3).

### 3.3.2. Hormone Therapy {#sec3.3.2}

Most of the studies \[[@B8], [@B11], [@B12], [@B14], [@B16], [@B18]--[@B22]\] excluded the TS girls that were treated with growth hormone and/or androgens. However, some studies \[[@B8]--[@B10], [@B13]--[@B15]\] included the girls that were treated with estrogens, and only three studies \[[@B8], [@B10], [@B14]\] analyzed the effects of treatment on the growth of TS girls. There was a significant increase in acceleration of growth during the first year of treatment \[[@B8], [@B14]\], but did not find significant differences on final height \[[@B10]\].

### 3.3.3. Karyotypes {#sec3.3.3}

The growth was analyzed in different karyotypes. The growth in TS girls with karyotype 45,X was lower in comparison to TS girls with other karyotypes \[[@B9], [@B12]\]. However, Isojima et al. \[[@B21]\] showed that the stature in children with 45,X was significantly higher than in other karyotypes. Other studies \[[@B10], [@B11], [@B13], [@B15], [@B17]--[@B20]\] found no significant differences.

### 3.3.4. Parents\' Height {#sec3.3.4}

Some studies \[[@B9], [@B10], [@B13]\] analyzed the relation between parental height and the height of girls with TS. Massa et al. \[[@B9]\] found significant positive correlation between the parental height and the height of girls with TS (*r* = 0.39). In the study of Naeraa and Nielsen \[[@B10]\], there was a significant correlation between mid-parental height and the adult height of girls with TS (*r* = 0.67; *n* = 65). Bernasconi et al. \[[@B13]\] demonstrated tendency towards higher girls size which can be attributable to the higher height means of mothers and fathers (TS: 146.3 ± 3.4 cm, mid-parental: 169.5 ± 3.4 cm versus TS: 139.9 ± 6.5 cm, mid-parental: 159.4 ± 3.7 cm).

### 3.3.5. Spontaneous Puberty and Menarche {#sec3.3.5}

Some studies analyzed the effects of spontaneous puberty \[[@B9], [@B13], [@B14], [@B19]\] and menarche occurrence \[[@B8], [@B11], [@B13], [@B14]\] on the final height in girls with TS, but found no significant differences with the induced puberty by hormone replacement, and the absence of menarche. In the study of Massa et al. \[[@B9]\], the TS girls aged 11 to 13 y with spontaneous puberty presented higher height and height velocity in comparison to TS girls with induced puberty.

### 3.3.6. Study Limitation {#sec3.3.6}

With regard to the reported limitations, only two studies \[[@B20], [@B21]\] described the methodological limitations for the construction of growth curves in TS girls. They reported the limitations with regard to selection bias, retrospective data, sample size in specific ages, cross-sectional design, and occurrence of puberty.

4. Discussion {#sec4}
=============

Growth curves are an important tool to evaluate child health \[[@B4], [@B23], [@B24]\]. In 2006, the WHO constructed new curves to follow child growth among diverse ethnic groups, socioeconomic conditions, and feeding mode \[[@B25]\]. However, the growth patterns of children with various diseases were not considered in international references.

Growth curves for TS girls were constructed in different countries. In this review, we describe the main methodological and statistical implications in each study. The curves have important strengths and weaknesses for application in the clinical practice. Some studies analyzed the effects of some confounder variable on the growth in girls with TS such as hormone therapy, spontaneous puberty, karyotypes, and mid-parental height. However, the relationship among the confounder variable and the acceleration or delays of growth appears to vary little in these studies. Length/height curves were found in all studies as well as height velocity in some studies. However, most did not generate curves for weight-for-age, head circumference-for-age, weight/height-for-age, and BMI-for-age. Although the TS girls have different genetic and phenotypic variations, the curves for weight, head circumference, and BMI should be more explored such as the curves of El-Bassyouni et al. \[[@B22]\], Isojima et al. \[[@B21]\], and Rongen-Westerlaken et al. \[[@B16]\].

The stature has increased in the last decades in general population. Isojima et al. \[[@B21]\] demonstrated that the adult height in TS girls followed in the studies of Suwa et al. \[[@B11]\], Isojima et al. \[[@B20]\], and Isojima et al. \[[@B21]\] was 138.2 cm, 141.2 cm, and 141.3 cm, respectively. Most studies followed the TS girls from 1950 to 1990, but did not analyze the growth in different time periods, and more than 50% of studies did not report the birth year period. Thus, we recommend the analysis of secular trend for construction of new growth curves for TS girls.

A strength observed in most studies was the number of observations for construction of curves. Considering the incidence of 1 : 2,500--3,000 girls born alive, the sample size appears to be representative, although the sample calculation is not indicated in the studies. The age interval was not thoroughly analyzed, and few studies used age interval every 3 months. It is difficult to precise the fitting of the curves from birth to 2 years of age. Another strength of the studies is that the girls treated with growth hormones or androgens were excluded of the samples. However, due to the use of retrospective data, there may be several cases omitted because of lack of information in the medical records. In addition, the selection bias may suggest a data bias in some situations, according to limitation reported by Isojima et al. \[[@B20]\]. With regard to environmental factors, no studies evaluated breastfeeding, lactation support, feeding mode, socioeconomic condition, maternal health, pediatric care, among others. de Onis et al. \[[@B26]\], demonstrated that the control of the environmental factors was necessary for construction of new curves as well as the selection of appropriate statistical methods for sample selection, data collection, and analysis.

A bias that is difficult to analyze is the karyotype, because often the information is not given. Over the decades, the techniques of realization of karyotype have improved and the results were significantly modified, decreasing the percentage of 45,X cases and increasing mosaicisms and structural aberrations of the sexual chromosomes \[[@B27]\].

For the construction of the curves, several statistical methods were used such as mean, standard deviation, percentile,*z*-score, and smoothing techniques. The first strength was the number of observations with means and standard deviations provided by most studies, thus allowing a greater accuracy when carrying out the comparisons between the various studies. The main statistical limitation observed in studies was the absence of important statistical methods for the construction of curves such as distribution and smoothing aspects. On the other hand, most studies used percentiles or*z*-score corresponding to −2 and +2. The distribution aspects of the anthropometric data should be analyzed as well as the estimation of percentiles related to age \[[@B28]\]. With regard to smoothing of curves, few studies have applied the LMS method to evaluate asymmetry, median, and data variability of Cole and Green \[[@B29]\]. The lack of smoothing techniques can lead to the construction of irregular curves, regardless of the use of large samples \[[@B28]\]. Moreover, Cole \[[@B30]\] shows that mean and SD for normal data are commonly used for the construction of curves as well as the LMS method for the treatment of asymmetry. According to the WHO \[[@B4]\], 30 statistical methods were reviewed for the construction of the 2006 growth curves. This involved the Box-Cox-power-exponential (BCPE), with curve smoothing by cubic splines. This demonstrates that the appropriate choice of statistical methods should be performed to construct growth curves. Thus, we suggested the examination of existing methods that will allow identifying the best statistical technique for construction of the growth curves in TS girls.

The strengths and limitations of growth curves should be carefully analyzed for clinical application in girls with TS. The main limitation for global use is their origination in a specific country. However, for countries that lack their own growth curve, we believe that the curves of Rongen-Westerlaken et al. \[[@B16]\] appear to be more suitable for clinical applications in children up to 2 years old mainly because the authors used age intervals every 3 months, generated curves for height, weight, BMI, and height velocity, and used high sample size. Moreover, for children above 2 years, we recommend the curves of Isojima et al. \[[@B21]\] for growth monitoring because the authors used high sample sizes and age intervals every 6 month up 20 years old. In addition, they considered secular trend, selection bias, and appropriate statistics.

5. Conclusion {#sec5}
=============

In the studies on growth curves in girls with TS, we observe the need to construct new curves for different ethnics group. For this, an important step in the construction of the new curves would be to analyze carefully the methodological and statistical aspects. Furthermore, for global use, we recommend a joint effort to produce a growth curve in TS girls for universal applicability. Finally, the findings of this review provide support for clinical practice guidelines for the monitoring of growth in girls with TS.
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###### 

Characteristics of the studies on growth curves.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                        Age\       Type\     HT\             SP %^e^ \    SM %^e^ \      Birth^f^   L/H   W     HC    W/H   BMI   HV    Country
                               (years)    (study)   (years)         (years)      (years)                                                       
  ---------------------------- ---------- --------- --------------- ------------ -------------- ---------- ----- ----- ----- ----- ----- ----- --------------
  Lyon et al.\                 1--20+     Mixed     Included\       h            8\             h          Yes   No    No    No    No    No    g
  1985 \[[@B8]\]                                    \>15                         (13--17)                                                      

  Massa et al.\                0--22      Mixed     Included\       17\          10\            h          Yes   No    No    No    No    Yes   Belgium
  1990 \[[@B9]\]                                    11.3--18        (11.1--15)   (13.7--15.2)                                                  

  Naeraa and Nielsen\          7--20^a^   h         Included\       h            9\             1955--66   Yes   No    No    No    No    Yes   Denmark
  1990 \[[@B10]\]                                   13.2--24.6                   (13--15)                                                      

  Suwa\                        0--20      Mixed     Excluded        h            3.3\           1955--89   Yes   No    No    No    No    Yes   Japan
  1992 \[[@B11]\]                                                                (11--14)                                                      

  Haeusler et al.\             0--16      Mixed     Excluded        18.4\        h              1961--81   Yes   No    No    No    No    Yes   Austria
  1992 \[[@B12]\]                                                   (no/age)                                                                   

  Bernasconi et al.\           0--21      Mixed     Included\       1.4\         4.4\           1950--90   Yes   No    No    No    No    No    Italy
  1994 \[[@B13]\]                                   (\>13)          (20.8)       (20.2)                                                        

  Garcia Rudaz et al.\         0--22      Mixed     Included\       12.7\        h\             h          Yes   No    No    No    No    Yes   Argentina
  1995 \[[@B14]\]                                   14 ± 1.2        (9--14)      (11--16.1)                                                    

  Sempe et al.\                0--20^b^   h         Included        h            h              h          Yes   No    No    No    No    Yes   France
  1996 \[[@B15]\]                                                                                                                              

  Rongen-Westerlaken et al.\   0--20      h         Included\       Excluded     h              h          Yes   Yes   No    Yes   Yes   Yes   Netherlands\
  1997 \[[@B16]\]                                   12.8--20.1^d^                                                                              Denmark\
                                                                                                                                               Sweden

  Even et al.\                 0--3       Long      h               h            h              h          Yes   No    No    No    No    Yes   Israel
  2000 \[[@B17]\]                                                                                                                              

  Davenport et al.\            0--8       Long      Excluded        Excluded     h              h          Yes   No    No    No    No    Yes   USA
  2002 \[[@B18]\]                                                                                                                              

  Román et al.\                0--18+     h         Excluded        10\          h              \>1968     Yes   No    No    No    No    No    Chile
  2002 \[[@B19]\]                                                   (no/age)                                                                   

  Isojima\                     0--20      Cross     Excluded        Excluded     h              1970--02   Yes   No    No    No    No    No    Japan
  et al. 2009 \[[@B20]\]                                                                                                                       

  Isojima\                     0--20      Cross     Excluded        Excluded     h              1970--06   Yes   Yes   No    Yes   Yes   Yes   Japan
  et al. 2010 \[[@B21]\]                                                                                                                       

  El-Bassyouni et al.\         6--24^c^   h         Excluded        h            h              h          Yes   Yes   Yes   No    Yes   No    Egypt
  2012 \[[@B22]\]                                                                                                                              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

HT: hormone therapy; SP: spontaneous puberty; SM: spontaneous menarche; L/H: length/height; W: weight; HC: head circumference; W/H: weight/height; BMI: body mass index; HV: height velocity; ^a^Height curve (7.5--17.5 years). ^b^Reference curves (1--21 years); ^c^6 months to 24 years; ^d^Age (10 and 90 percentile); ^e^Percentage frequency; ^f^Birth year period; ^g^Data derived from studies (Germany---Pelz et al. \[[@B31]\]; Germany---Ranke et al. \[[@B32]\]; Finland---Lenko et al. \[[@B33]\]; France---Rosenberg and Tell \[[@B34]\]); ^h^Data not available.

###### 

Size sample and karyotypes of the studies.

  --------------------------------------------------------------------------------------------------
  Study                    *n* ^a^   *n* ^b^   Karyotype (%)                               
  ------------------------ --------- --------- --------------- --------- -------- -------- ---------
  Lyon et al.\             366       1517      61.8^e^         16.9^e^   4.1^e^   4.6^e^   12.6^e^
  1985 \[[@B8]\]                                                                           

  Massa et al.\            100       637       47              7         5        13       28
  1990 \[[@B9]\]                                                                           

  Naeraa and Nielsen\      78        1174      63              3         c        8        26
  1990 \[[@B10]\]                                                                          

  Suwa\                    704       6255      36.1            c         9.8      0        54.1
  1992 \[[@B11]\]                                                                          

  Haeusler et al.\         141       580       67.3            7         2.8      9.2      13.7
  1992 \[[@B12]\]                                                                          

  Bernasconi et al.\       772       c         56.3            9.8       7.3      10.9     15.7
  1994 \[[@B13]\]                                                                          

  Garcia Rudaz et al.\     254       2308      47              15        7        11       20
  1995 \[[@B14]\]                                                                          

  Sempe et al.\            167       708       58.1            31.7      c        c        10.2
  1996 \[[@B15]\]                                                                          

  Rongen-Westerlaken\      598       9011      c               c         c        c        c
  et al. 1997 \[[@B16]\]                                                                   

  Even et al.\             47        c         48.9            c         23.4     c        27.7
  2000 \[[@B17]\]                                                                          

  Davenport et al.\        112       1146      57.1            12.5      4.5      c        25.9
  2002 \[[@B18]\]                                                                          

  Román et al.\            83        668       60              25        2        9        4
  2002 \[[@B19]\]                                                                          

  Isojima et al.\          1447      1447^d^   29.9            6         8.8      21.4     33.9
  2009 \[[@B20]\]                                                                          

  Isojima et al.\          1565      5772      29.6            6.1       8.8      21       34.5
  2010 \[[@B21]\]                                                                          

  El-Bassyouni et al.\     93        c         59.1            40.9      c        c        c
  2012 \[[@B22]\]                                                                          

                                                                                           

  Total                    6273      28915                                                  
  --------------------------------------------------------------------------------------------------

*n* ^a^: number of subjects; *n* ^b^: number of observations.

^c^Data not available.

^d^Mentioned in Isojima et al. 2010 \[[@B21]\].

^e^Data derived from studies (Pelz et al. \[[@B31]\]; Ranke et al. \[[@B32]\]; Lenko et al. \[[@B33]\]; Rosenberg and Tell \[[@B34]\]).

###### 

Number of observations, means, and standard deviations (SD) for height in girls with Turner syndrome.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Age\   Lyon et al.\     Massa et al.\    Naeraa and Nielsen\   Garcia Rudaz et al.\   Rongen-Westerlaken et al.\   Román et al.\     Isojima et al.\                                                                                           
  (y)    1985 \[[@B8]\]   1990 \[[@B9]\]   1990 \[[@B10]\]       1995 \[[@B14]\]        1997 \[[@B16]\]              2002 \[[@B19]\]   2010 \[[@B21]\]                                                                                           
  ------ ---------------- ---------------- --------------------- ---------------------- ---------------------------- ----------------- ----------------- ------- ----- ---- ------- ----- ----- ------- ----- ----- ------- ----- ----- -------- ------
  0      ---              ---              ---                   23                     48                           1.9               ---               ---     ---   18   46.4    3.5   213   47.9    2.8   42    46.8    2.1   338   ---      ---

  1      81               63.8             6.8                   8                      69.3                         3.3               ---               ---     ---   19   65.3    3.9   182   70.0    2.5   44    73.0    3.9   240   68.79    2.83

  2      52               77.5             3.5                   11                     79.4                         3.4               ---               ---     ---   18   77.1    4.1   223   80.8    3.0   32    80.0    4.2   208   77.62    3.03

  3      64               84.2             4.7                   13                     87.2                         4.4               ---               ---     ---   18   85.7    4.1   234   87.1    3.5   50    85.5    4.7   364   84.25    3.17

  4      58               91.1             5.5                   17                     91.1                         3.6               ---               ---     ---   23   92.2    4.2   247   94.0    3.6   34    91.4    4.2   376   89.56    3.29

  5      66               96.5             5.0                   19                     97.8                         3.8               ---               ---     ---   33   97.4    4.2   226   99.6    4.4   61    96.7    4.0   393   94.66    3.42

  6      79               103.1            6.4                   27                     102.4                        3.8               ---               ---     ---   42   101.8   4.4   249   104.7   4.2   25    102.1   5.6   447   99.86    3.59

  7      77               106.0            5.0                   27                     106.8                        4.1               32                108.9   5.4   52   105.9   4.6   260   109.4   4.5   52    106.2   7.6   469   104.96   3.80

  8      83               111.4            6.6                   28                     110.5                        4.3               63                113.6   4.6   55   109.8   4.9   259   114.0   4.7   27    108.9   5.8   477   109.63   4.02

  9      97               115.0            5.7                   29                     115.1                        4.4               66                117.8   4.7   67   113.8   5.2   262   118.0   4.9   64    112.3   4.2   557   114.27   4.25

  10     93               119.5            6.4                   38                     120.1                        4.5               69                121.6   4.8   82   117.8   5.5   263   121.8   4.8   31    116.7   5.1   511   118.82   4.48

  11     84               122.8            6.2                   33                     124.8                        5.2               69                125.4   4.9   86   121.7   5.8   252   125.8   4.9   89    120.2   5.5   413   123.14   4.70

  12     105              126.5            5.9                   41                     128.4                        5.4               68                129.0   5.1   91   125.5   6.0   233   130.0   5.3   68    122.8   5.7   308   127.25   4.89

  13     85               130.7            5.8                   44                     132.5                        6.1               69                132.4   5.0   90   129.0   6.2   224   133.4   5.6   71    125.8   7.2   209   131.12   5.07

  14     85               132.6            5.9                   48                     135.9                        5.9               66                135.8   5.1   93   132.1   6.2   178   136.5   5.8   32    130.3   7.9   163   134.13   5.21

  15     84               135.8            5.7                   49                     138.2                        6.2               60                138.6   5.0   93   134.5   6.0   135   139.9   5.8   30    133.5   9.0   117   136.13   5.31

  16     84               138.6            5.4                   52                     140.0                        5.7               49                140.2   5.1   87   136.3   5.7   107   140.8   6.0   ---   ---     ---   82    137.64   5.38

  17     52               140.6            6.0                   43                     141.6                        6.1               34                142.3   4.8   77   137.4   5.4   72    141.8   5.1   ---   ---     ---   42    138.76   5.43

  18     26               143.4            6.3                   33                     142.5                        6.0               ---               ---     ---   62   137.8   5.1   45    143.7   5.2   ---   ---     ---   21    139.51   5.46
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Flavia Prodam
